Latest Breaking News On - ஆவணம் இடம் சர்வதேச இன்க் - Page 1 : comparemela.com

Breast Cancer Cells Through Multiple Pathways   LONDON/TORONTO, Apollon Formularies plc (AQSE: APOL, Apollon or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION, Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells grown in 3D cell culture via three separate mechanisms: direct cell cytotoxicity, immune stimulated T-cell cytotoxicity, and macrophage induced phagocytosis. HER2-positive constitutes approximately 20% of all breast cancers.   The testing was performed by BIOENSIS, an independent, pre-clinical predictive pharmaceutical testing laboratory. The medical cannabis formulations were developed by Apollon s affiliate, Apollon Formularies Jamaica Limited ( Apollon Jamaica ), and the medicinal mushroom f

United statesUnited kingdomCity ofHerberta fritscheGraham simmondsTrastuzumab herceptinStephend barnhillMegan rayPaul burkeTim blytheStene jacobsAion therapeutic incApollon formularies jamaicaDoc place international incMd anderson cancer centerResearch development